Literature DB >> 21091148

Thromboembolic and bleeding complications in acute leukemia.

Hau C Kwaan1, Timothy Huyck.   

Abstract

The risk of both thromboembolic and bleeding complications is high in acute leukemia. This double hazard has a significant negative impact on the morbidity and mortality of patients with this disease. The clinical manifestations of both complications show special features specific to the form of acute leukemia. Recognition of these characteristics is important in the diagnosis and management of acute leukemia. In this article, several additional issues are addressed, including the features of bleeding and thrombosis in acute promyelocytic leukemia, the current understanding of the leukostasis syndrome and the iatrogenic complications including catheter-associated thrombosis, and the adverse effects of therapeutic agents used in acute leukemia. As regards the bleeding complications, thrombocytopenia is a major cause. Corrective measures, including recent guidelines on platelet transfusions, are provided.

Entities:  

Mesh:

Year:  2010        PMID: 21091148     DOI: 10.1586/ehm.10.71

Source DB:  PubMed          Journal:  Expert Rev Hematol        ISSN: 1747-4094            Impact factor:   2.929


  5 in total

1.  Transient ischemic attack as an unusual initial manifestation of acute promyelocytic leukemia.

Authors:  Lifeng Liu; Xiaoling Yuan
Journal:  Int J Hematol       Date:  2016-03-16       Impact factor: 2.490

2.  Retrospective Evaluation of New Chinese Diagnostic Scoring System for Disseminated Intravascular Coagulation.

Authors:  Manzhi Wang; Haiming Kou; Jun Deng; Huafang Wang; Tao Guo; Heng Mei; Yu Hu
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

3.  2-Arachidonoylglycerol enhances platelet formation from human megakaryoblasts.

Authors:  Valeria Gasperi; Luciana Avigliano; Daniela Evangelista; Sergio Oddi; Valerio Chiurchiù; Mirko Lanuti; Mauro Maccarrone; Maria Valeria Catani
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

4.  Molecular basis for the diagnosis and treatment of acute promyelocytic leukemia.

Authors:  Sarah Cristina Bassi; Eduardo Magalhães Rego
Journal:  Rev Bras Hematol Hemoter       Date:  2012

Review 5.  Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia.

Authors:  Guilherme Augusto Dos Santos; Lev Kats; Pier Paolo Pandolfi
Journal:  J Exp Med       Date:  2013-12-16       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.